noscript

News and Announcements

First Two Patients in Clinical Trial for Canine Cancer Begin Treatment

  • Published October 23, 2014 9:36AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

ASX Release – Wednesday 22nd October 2014 

PharmAust Limited (ASX:PAA & PAAO) is pleased to announce that it has now initiated its trial of PPL-1 in dogs for the treatment of canine cancers. Within the last week, two dogs have begun treatment with PPL-1 formulated in “soft-gel” capsules to determine the safety and efficacy of PPL-1 in various canine cancers.

Dr Angela Frim berger of the Animal Referral Hospital (ARH) in Homebuss, NSW and Principal Investigator in the trial said,” The palatability issues of PPL-1 in dogs have largely been resolved by reformulation of PPL-1 into a tasteless, soft gel capsule making administration to pets by their owners far more practicable. Following our call for accrual of canine patients, we are seeing good progress in patient recruitment.”

To view the full ASX release, please click here. 

 

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now